Tara Bancroft
Stock Analyst at TD Cowen
(2.84)
# 1,712
Out of 4,896 analysts
8
Total ratings
66.67%
Success rate
26.66%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TGTX TG Therapeutics | Initiates: Buy | $50 | $37.09 | +34.83% | 1 | Oct 29, 2024 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $65 | $53.03 | +22.58% | 1 | Sep 24, 2024 | |
| OCUL Ocular Therapeutix | Upgrades: Buy | $7 → $11 | $11.03 | -0.27% | 3 | Jun 20, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $1.32 | +657.58% | 1 | Apr 29, 2024 | |
| MRUS Merus | Initiates: Outperform | n/a | $54.54 | - | 1 | Aug 21, 2023 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $8.00 | - | 1 | Aug 31, 2022 |
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $37.09
Upside: +34.83%
Protagonist Therapeutics
Sep 24, 2024
Initiates: Buy
Price Target: $65
Current: $53.03
Upside: +22.58%
Ocular Therapeutix
Jun 20, 2024
Upgrades: Buy
Price Target: $7 → $11
Current: $11.03
Upside: -0.27%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $1.32
Upside: +657.58%
Merus
Aug 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $54.54
Upside: -
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $8.00
Upside: -